Biography - Samir Mehta ::

With his brother managing the Torrent conglomerate single handedly, Shri Samir Mehta joined to provide him with a helping hand to oversee the expanding business. He brought with him not only the genius and acumen of a trained businessman but also provided a youthful and exuberant attitude.

Born in 1963, Shri Mehta completed his early education in Seth Shri C.N. Vidhyalaya, Ahmedabad and graduated from HL College of Commerce.

He followed this up with the necessary foundation for running the pharma business already flourishing under the able guidance of his father, by gaining practical and academic knowledge through a Master's Degree in Business Administration from one of the city's best business schools, BK School of Management.

At the age of 22, he began his illustrious career alongside his brother to provide his contributions for the development of the organisation.

He took over the management of the pharma business of the Torrent conglomerate, which was concentrating particularly in psychotropic drugs manufactured in their own plant at Vatva and with a clear focus on exports.

Apart from overseeing the improvement in operation and manufacturing facilities, he also focused on changes through innovative ideas in the areas of HR, finance and general management.

Under his stewardship, Torrent also ventured into the high technology field of Medical Electronics. There was greater emphasis on therapeutic segments, which was exhibited by the creation of a specialized Torrent Novo division to deal with diabetes care products.

With his zeal for spreading the umbrella of Torrent Pharmaceuticals, the Company took a leap with an impetus to entry into the international markets making it the leading exporter of healthcare products in the country.

With his keen interest in strategic decision and management of the pharma division there has been significant growth for the Company in the pharmaceuticals sector.

An ardent believer in professionalism, Shri Samir Mehta has not left any stone unturned to ensure that his efforts reap gainful successes for the Group and the pharma sector particularly.